Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan

Journal of Medical Virology

Volumn 79, Issue 4, 2007, Pages 366-373

  Hayashi, Kazuhiko ^a   Katano, Yoshiaki ^a   Takeda, Yasushi ^a   Honda, Takashi ^a   Ishigami, Masatoshi ^a   Itoh, Akihiro ^a   Hirooka, Yoshiki ^a   Nakano, Isao ^a   Yano, Motoyoshi ^a   Goto, Hidemi ^a   Yoshioka, Kentaro ^b   Toyoda, Hidenori ^c   Kumada, Takashi ^c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Drug resistance; Genotype; Phylogenetic analysis

Indexed keywords

LAMIVUDINE;

ACUTE HEPATITIS; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHRONIC HEPATITIS; DNA SEQUENCE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; NUCLEOTIDE SEQUENCE; PREVALENCE; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS CLASSIFICATION; VIRUS DETECTION; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TYPING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; JAPAN; LAMIVUDINE; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; REVERSE TRANSCRIPTASE INHIBITORS; SPECIES SPECIFICITY; VIRAL PROTEINS;

HEPATITIS B VIRUS;

EID: 33847678968     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20824     Document Type: Article

References (36)

1. Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, Brown N, Condreay LD. 1998. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27:1670-1677.
2. Brenner B, Routy JP, Quan Y, Moisi D, Oliveira M, Turner D, Wainberg MA; Co-Investigators of the Quebec Primary Infection Study. 2004. Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection. AIDS 18:1653-1660.
3. Chan HL, Tsui SK, Tse CH, Ng EY, Au TC, Yuen L, Bartholomeusz A, Leung KS, Lee KH, Locarnini S, Sung JJ. 2005. Epidemiological and virological characteristics of 2 subgroups of hepatitis B virus genotype C. J Infect Dis 191:2022-2232.
4. Chen BF, Kao JH, Liu CJ, Chen DS, Chen PJ. 2004. Genotypic dominance and novel recombinations in HBV genotype B and C co-infected intravenous drug users. J Med Virol 73:13-22.
5. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Jr., Luketic VA, Terrault N, Lok AS; U.S. HBV Epidemiology Study Group. 2003. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 38:619-628.
6. Ganem D, Prince AM. 2004. Hepatitis B virus infection-Natural history and clinical consequences. N Engl J Med 350:1118-1129.
7. Hadziyannis SJ, Papatheodoridis GV, Dimou E, Laras A, Papaioannou C. 2000. Efficacy of long-term lamivudine monotherapy in patients with hepatitis Be antigen-negative chronic hepatitis B. Hepatology 32:847-851.
8. Huy TT, Ushijima H, Quang VX, Win KM, Luengrojanakul P, Kikuchi K, Sata T, Abe K. 2004. Genotype C of hepatitis B virus can be classified into at least two subgroups. J Gen Virol 85:283-292.
9. Joh R, Hasegawa K, Ogawa M, Ishikawa K, lizuka A, Naritomi T, Kanai N, Torii N, Hashimoto E, Hayashi N. 2003. Genotypic analysis of hepatitis B virus from patients with fulminant hepatitis: Comparison with acute self-limited hepatitis. Hepatol Res 26:119-124.
10. Kao JH, Chen DS. 2002. Global control of hepatitis B virus infection. Lancet Infect Dis. 2:395-403.
11. Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E. 2004. Hepatocellular carcinoma: Recent trends in Japan. Gastroenterology 127:817-26.
12. Kobayashi M, Suzuki F, Arase Y, Akuta N, Suzuki Y, Hosaka T, Saitoh S, Kobayashi M, Tsubota A, Someya T, Ikeda K, Matsuda M, Sato J, Kumada H. 2001. Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001. J Gastroenterol. 39:844-850.
13. Koibuchi T, Hitani A, Nakamura T, Nojiri N, Nakajima K, Jyuji T, Iwamoto A. 2001. Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan. J Med Virol. 64:435-440.
14. Kondili LA, Osman H, Mutimer D. 2004. The use of lamivudine for patients with acute hepatitis B (a series of cases). J Viral Hepat 11:427-431.
15. Kurbanov F, Tanaka Y, Fujiwara K, Sugauchi F, Mbanya D, Zekeng L, Ndembi N, Ngansop C, Kaptue L, Miura T, Ido E, Hayami M, Ichimura H, Mizokami M. 2005. A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J Gen Virol 86:2047-2056.
16. Liaw YF, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Chien RN, Dent J, Roman L, Edmundson S, Lai CL. 2000. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology 119:172-180.
17. Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P. 1999. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 179:775-782.
18. Melegari M, Scaglioni PP, Wands JR. 1998. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 27:628-633.
19. Michitaka K, Onji M. 2004. Hepatitis B virus genotypes in Japan-Past, present, and future. J Gastroenterol 39:911-912.
20. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
21. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M. 1988. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J Gen Virol 69:2575-2583.
22. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. 1991. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 324:1699-1704.
23. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, Okita K, Okanoue T, Iino S, Tanaka E, Suzuki K, Watanabe H, Hige S, Mizokami M. 2001. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 34:590-594.
24. Orito E, Sugauchi F, Tanaka Y, Ichida T, Sata M, Tanaka E, Okanoue T, Sakugawa H, Watanabe H, Miyakawa H, Nishiguchi S, Kumada H, Ueda R, Mizokami M. 2005. Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan. Intervirology 48:239-245.
25. Perrillo R, Schiff E, Yoshida E, Statler A, Hirsch K, Wright T, Gutfreund K, Lamy P, Murray A. 2000. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 32:129-134.
26. Perrillo R, Hann HW, Mutimer D, Willems B, Leung N, Lee WM, Moorat A, Gardner S, Woessner M, Bourne E, Brosgart CL, Schiff E. 2004. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology 126:81-90.
27. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425.
28. Schmilovitz-Weiss H, Ben-Ari Z, Sikuler E, Zuckerman E, Sbeit W, Ackerman Z, Safadi R, Lurie Y, Rosner G, Tur-Kaspa R, Reshef R. 2004. Lamivudine treatment for acute severe hepatitis B: A pilot study. Liver Int 24:547-551.
29. Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, Ishida T, Chutaputti A, Lai CL, Gish RG, Ueda R, Miyakawa Y, Mizokami M. 2003. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology 124:925-932.
30. Suzuki F, Tsubota A, Akuta N, Someya T, Kobayashi M, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Miyakawa Y, Kumada H. 2002. Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy. J Gastroenterol 37:922-927.
31. Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S. 1998. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: Comparative analysis of 40 full-length isolates. Arch Virol 143:2313-2326.
32. Takeda Y, Katano Y, Hayashi K, Honda T, Yokozaki S, Nakano I, Yano M, Yoshioka K, Toyoda H, Kumada T, Goto H. 2006. Difference of HBV genotype distribution between acute hepatitis and chronic hepatitis in Japan. Infection 34:201-207.
33. Tanaka Y, Orito E, Yuen MF, Mukaide M, Sugauchi F, Ito K, Ozasa A, Sakamoto T, Kurbanov F, Lai CL, Mizokami M. 2005. Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism. Hepatol Res 33:216-224.
34. Wang Z, Liu Z, Zeng G, Wen S, Qi Y, Ma S, Naoumov NV, Hou J. 2005. A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China. J Gen Virol 86:985-990.
35. Wu CH, Ouyang EC, Walton C, Promrat K, Forouhar F, Wu GY. 2003. Hepatitis B virus infection of transplanted human hepatocytes causes a biochemical and histological hepatitis in immunocopetentent rats. World J Gastroenterol 9:978-983.
36. Yotsuyanagi H, Okuse C, Yasuda K, Orito E, Nishiguchi S, Toyoda J, Tomita E, Hino K, Okita K, Murashima S, Sata M, Hoshino H, Miyakawa Y, Iino S, Japanese Acute Hepatitis B Group. 2005. Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan. J Med Virol 77:39-46.